<?xml version="1.0" encoding="UTF-8"?>
<TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink"
            xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
            xmlns="ted/R2.0.9.S02/publication"
            xmlns:n2016="ted/2016/nuts"
            xsi:schemaLocation="ted/R2.0.9.S02/publication TED_EXPORT.xsd"
            VERSION="R2.0.9.S02.E01"
            DOC_ID="015699-2018"
            EDITION="2018009">
   <TECHNICAL_SECTION>
      <RECEPTION_ID>18-015579-001</RECEPTION_ID>
      <DELETION_DATE>20180421</DELETION_DATE>
      <FORM_LG_LIST>SV </FORM_LG_LIST>
      <COMMENTS>From Convertor</COMMENTS>
   </TECHNICAL_SECTION>
   <LINKS_SECTION>
      <XML_SCHEMA_DEFINITION_LINK xlink:type="simple"
                                  xlink:href="http://ted.europa.eu"
                                  xlink:title="TED WEBSITE"/>
      <OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_CPV_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
      <ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/>
   </LINKS_SECTION>
   <CODED_DATA_SECTION>
      <REF_OJS>
         <COLL_OJ>S</COLL_OJ>
         <NO_OJ>9</NO_OJ>
         <DATE_PUB>20180113</DATE_PUB>
      </REF_OJS>
      <NOTICE_DATA>
         <NO_DOC_OJS>2018/S 009-015699</NO_DOC_OJS>
         <URI_LIST>
            <URI_DOC LG="SV">http://ted.europa.eu/udl?uri=TED:NOTICE:015699-2018:TEXT:SV:HTML</URI_DOC>
         </URI_LIST>
         <LG_ORIG>SV</LG_ORIG>
         <ISO_COUNTRY VALUE="SE"/>
         <IA_URL_GENERAL>http://www.fmv.se</IA_URL_GENERAL>
         <ORIGINAL_CPV CODE="33650000">General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents</ORIGINAL_CPV>
         <n2016:PERFORMANCE_NUTS CODE="SE">SVERIGE</n2016:PERFORMANCE_NUTS>
         <n2016:CA_CE_NUTS CODE="SE">SVERIGE</n2016:CA_CE_NUTS>
         <REF_NOTICE>
            <NO_DOC_OJS>2017/S 162-333834</NO_DOC_OJS>
         </REF_NOTICE>
      </NOTICE_DATA>
      <CODIF_DATA>
         <DS_DATE_DISPATCH>20180111</DS_DATE_DISPATCH>
         <AA_AUTHORITY_TYPE CODE="N">National or federal Agency/Office</AA_AUTHORITY_TYPE>
         <TD_DOCUMENT_TYPE CODE="7">Contract award notice</TD_DOCUMENT_TYPE>
         <NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE>
         <PR_PROC CODE="1">Open procedure</PR_PROC>
         <RP_REGULATION CODE="5">European Union, with participation by GPA countries</RP_REGULATION>
         <TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID>
         <AC_AWARD_CRIT CODE="1">Lowest price</AC_AWARD_CRIT>
         <MA_MAIN_ACTIVITIES CODE="D">Defence</MA_MAIN_ACTIVITIES>
         <HEADING>01B03</HEADING>
         <INITIATOR>01</INITIATOR>
         <DIRECTIVE VALUE="2014/24/EU"/>
      </CODIF_DATA>
   </CODED_DATA_SECTION>
   <TRANSLATION_SECTION>
      <ML_TITLES>
         <ML_TI_DOC LG="BG">
            <TI_CY>Швeция</TI_CY>
            <TI_TOWN>Karlskrona</TI_TOWN>
            <TI_TEXT>
               <P>Общи противовъзпалителни средства за системна употреба, ваксини, антинеопласти и имуномодулатори</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="CS">
            <TI_CY>Švédsko</TI_CY>
            <TI_TOWN>Karlskrona</TI_TOWN>
            <TI_TEXT>
               <P>Antiinfektiva pro systémové užití, očkovací látky, antineoplastika a imunomodulátory</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DA">
            <TI_CY>Sverige</TI_CY>
            <TI_TOWN>Karlskrona</TI_TOWN>
            <TI_TEXT>
               <P>Antiinfektive midler til systemisk brug, vacciner, cytostatike/cytotoxiske midler samt immunmodulerende midler</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="DE">
            <TI_CY>Schweden</TI_CY>
            <TI_TOWN>Karlskrona</TI_TOWN>
            <TI_TEXT>
               <P>Antiinfektiva zur systemischen Anwendung, Impfstoffe, Antineoplastika und Immunmodulatoren</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EL">
            <TI_CY>Σουηδία</TI_CY>
            <TI_TOWN>Karlskrona</TI_TOWN>
            <TI_TEXT>
               <P>Φάρμακα κατά των λοιμώξεων συστηματικής χρήσης, εμβόλια, αντινεοπλασματικά και ανοσορρυθμιστικά φάρμακα</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="EN">
            <TI_CY>Sweden</TI_CY>
            <TI_TOWN>Karlskrona</TI_TOWN>
            <TI_TEXT>
               <P>General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ES">
            <TI_CY>Suecia</TI_CY>
            <TI_TOWN>Karlskrona</TI_TOWN>
            <TI_TEXT>
               <P>Antiinfecciosos generales para uso sistémico, vacunas, antineoplásicos e inmunomoduladores</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="ET">
            <TI_CY>Rootsi</TI_CY>
            <TI_TOWN>Karlskrona</TI_TOWN>
            <TI_TEXT>
               <P>Üldised infektsioonivastased ained süsteemseks kasutamiseks, vaktsiinid, antineoplastilised ja immuunmoduleerivad ained</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FI">
            <TI_CY>Ruotsi</TI_CY>
            <TI_TOWN>Karlskrona</TI_TOWN>
            <TI_TEXT>
               <P>Systeemisesti vaikuttavat infektiolääkkeet, rokotteet sekä syöpälääkkeet ja immunomodulantit</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="FR">
            <TI_CY>Suède</TI_CY>
            <TI_TOWN>Karlskrona</TI_TOWN>
            <TI_TEXT>
               <P>Anti-infectieux généraux à usage systémique, vaccins, antinéoplasiques et immunomodulateurs</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="GA">
            <TI_CY>Sualainn, an t</TI_CY>
            <TI_TOWN>Karlskrona</TI_TOWN>
            <TI_TEXT>
               <P>General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HR">
            <TI_CY>Švedska</TI_CY>
            <TI_TOWN>Karlskrona</TI_TOWN>
            <TI_TEXT>
               <P>Opća protuupalna sredstva za sustavno liječenje, cjepiva, antineoplastična sredstva i imunomodulatori</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="HU">
            <TI_CY>Svédország</TI_CY>
            <TI_TOWN>Karlskrona</TI_TOWN>
            <TI_TEXT>
               <P>Általános fertőzésellenes szerek szisztémás használatra, vakcinák, daganatellenes és immunmodulátor szerek</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="IT">
            <TI_CY>Svezia</TI_CY>
            <TI_TOWN>Karlskrona</TI_TOWN>
            <TI_TEXT>
               <P>Antinfettivi generali per uso sistemico, vaccini, agenti antineoplastici e immunomodulatori</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LT">
            <TI_CY>Švedija</TI_CY>
            <TI_TOWN>Karlskrona</TI_TOWN>
            <TI_TEXT>
               <P>Sistemiškai veikiantys priešinfekciniai vaistai, vakcinos, antinavikiniai vaistai ir imunomoduliatoriai</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="LV">
            <TI_CY>Zviedrija</TI_CY>
            <TI_TOWN>Karlskrona</TI_TOWN>
            <TI_TEXT>
               <P>Vispārēji pretinfekcijas līdzekļi sistēmiskai lietošanai, vakcīnas, antineoplastiskie līdzekļi un imūnmodulatori</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="MT">
            <TI_CY>l-Isvezja</TI_CY>
            <TI_TOWN>Karlskrona</TI_TOWN>
            <TI_TEXT>
               <P>Anti-infettivi ġenerali għall-użu sistematiku, vaċċini, antineoplastika u aġenti immunomodulaturi</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="NL">
            <TI_CY>Zweden</TI_CY>
            <TI_TOWN>Karlskrona</TI_TOWN>
            <TI_TEXT>
               <P>Algemene infectiewerende middelen voor systemisch gebruik, vaccins, antineoplastica en immunomodulerende middelen</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PL">
            <TI_CY>Szwecja</TI_CY>
            <TI_TOWN>Karlskrona</TI_TOWN>
            <TI_TEXT>
               <P>Ogólne środki przeciwinfekcyjne do użytku ogólnoustrojowego, szczepionki, środki przeciwnowotworowe oraz immunomodulacyjne</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="PT">
            <TI_CY>Suécia</TI_CY>
            <TI_TOWN>Karlskrona</TI_TOWN>
            <TI_TEXT>
               <P>Anti-infecciosos gerais de uso sistémico, vacinas, antineoplásicos e imunomoduladores</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="RO">
            <TI_CY>Suedia</TI_CY>
            <TI_TOWN>Karlskrona</TI_TOWN>
            <TI_TEXT>
               <P>Antiinfecţioase generale pentru uz sistemic, vaccinuri, antineoplazice şi imunomodulatoare</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SK">
            <TI_CY>Švédsko</TI_CY>
            <TI_TOWN>Karlskrona</TI_TOWN>
            <TI_TEXT>
               <P>Všeobecné antiinfekčné látky na systémové použitie, očkovacie látky, antineoplastické prostriedky a imunomodulačné činidlá</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SL">
            <TI_CY>Švedska</TI_CY>
            <TI_TOWN>Karlskrona</TI_TOWN>
            <TI_TEXT>
               <P>Antimikotiki za sistemsko zdravljenje, cepiva, zdravila z delovanjem na novotvorbe in imunomodulatorji</P>
            </TI_TEXT>
         </ML_TI_DOC>
         <ML_TI_DOC LG="SV">
            <TI_CY>Sverige</TI_CY>
            <TI_TOWN>Karlskrona</TI_TOWN>
            <TI_TEXT>
               <P>Antiinfektiva medel för systemiskt bruk, vacciner, cytostatika/cytotoxiska medel, samt immunmodulerande medel</P>
            </TI_TEXT>
         </ML_TI_DOC>
      </ML_TITLES>
      <ML_AA_NAMES>
         <AA_NAME LG="SV">FÖRSVARETS MATERIELVERK</AA_NAME>
      </ML_AA_NAMES>
   </TRANSLATION_SECTION>
   <FORM_SECTION>
      <F03_2014 CATEGORY="ORIGINAL" FORM="F03" LG="SV">
         <CONTRACTING_BODY>
            <ADDRESS_CONTRACTING_BODY>
               <OFFICIALNAME>FÖRSVARETS MATERIELVERK</OFFICIALNAME>
               <NATIONALID>202100-0340</NATIONALID>
               <ADDRESS>Box 527</ADDRESS>
               <TOWN>Karlskrona</TOWN>
               <POSTAL_CODE>37123</POSTAL_CODE>
               <COUNTRY VALUE="SE"/>
               <CONTACT_POINT>Jenny Karlsson</CONTACT_POINT>
               <PHONE>+46 766492458</PHONE>
               <E_MAIL>jenny.karlsson@fmv.se</E_MAIL>
               <n2016:NUTS CODE="SE"/>
               <URL_GENERAL>http://www.fmv.se</URL_GENERAL>
            </ADDRESS_CONTRACTING_BODY>
            <CA_TYPE VALUE="NATIONAL_AGENCY"/>
            <CA_ACTIVITY VALUE="DEFENCE"/>
         </CONTRACTING_BODY>
         <OBJECT_CONTRACT>
            <TITLE>
               <P>Vaccin</P>
            </TITLE>
            <REFERENCE_NUMBER>UH-2017-488</REFERENCE_NUMBER>
            <CPV_MAIN>
               <CPV_CODE CODE="33650000"/>
            </CPV_MAIN>
            <TYPE_CONTRACT CTYPE="SUPPLIES"/>
            <SHORT_DESCR>
               <P>Upphandlingen omfattar vaccin för FMs behov. FMV avser att teckna ramavtal med en eller flera leverantörer för att täcka behovet av angivna vaccin se bilaga 4 Varukorg, dock max en leverantör per vaccin på sjuställig ATC-kod.</P>
            </SHORT_DESCR>
            <NO_LOT_DIVISION/>
            <OBJECT_DESCR ITEM="1">
               <n2016:NUTS CODE="SE"/>
               <SHORT_DESCR>
                  <P>Upphandlingen omfattar vaccin för FMs behov. FMV avser att teckna ramavtal med en eller flera leverantörer för att täcka behovet av angivna vaccin se bilaga 4 Varukorg, dock max en leverantör per vaccin på sjuställig ATC-kod.</P>
               </SHORT_DESCR>
               <AC_PRICE/>
               <NO_OPTIONS/>
               <NO_EU_PROGR_RELATED/>
            </OBJECT_DESCR>
         </OBJECT_CONTRACT>
         <PROCEDURE>
            <PT_OPEN/>
            <CONTRACT_COVERED_GPA/>
            <NOTICE_NUMBER_OJ>2017/S 162-333834</NOTICE_NUMBER_OJ>
         </PROCEDURE>
         <AWARD_CONTRACT ITEM="1">
            <TITLE>
               <P>Vaccin</P>
            </TITLE>
            <NO_AWARDED_CONTRACT>
               <PROCUREMENT_UNSUCCESSFUL/>
            </NO_AWARDED_CONTRACT>
         </AWARD_CONTRACT>
         <COMPLEMENTARY_INFO>
            <ADDRESS_REVIEW_BODY>
               <OFFICIALNAME>Förvaltningsrätten i Stockholm och migrationsdomstol</OFFICIALNAME>
               <TOWN>Stockholm</TOWN>
               <POSTAL_CODE>115 76</POSTAL_CODE>
               <COUNTRY VALUE="SE"/>
               <PHONE>+46 8-56168000</PHONE>
               <E_MAIL>forvaltningsrattenistockholm@dom.se</E_MAIL>
               <FAX>+46 8-56168001</FAX>
               <URL>http://www.forvaltningsrattenistockholm.domstol.se</URL>
            </ADDRESS_REVIEW_BODY>
            <ADDRESS_MEDIATION_BODY>
               <OFFICIALNAME>GlaxoSmithKline AB</OFFICIALNAME>
               <TOWN>Stockholm</TOWN>
               <COUNTRY VALUE="SE"/>
            </ADDRESS_MEDIATION_BODY>
            <ADDRESS_REVIEW_INFO>
               <OFFICIALNAME>Sanofi Pasteur AB</OFFICIALNAME>
               <TOWN>Stockholm</TOWN>
               <COUNTRY VALUE="SE"/>
            </ADDRESS_REVIEW_INFO>
            <DATE_DISPATCH_NOTICE>2018-01-11</DATE_DISPATCH_NOTICE>
         </COMPLEMENTARY_INFO>
      </F03_2014>
   </FORM_SECTION>
</TED_EXPORT>
